Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 801. The contact email is not on this page.
- BRAIN THRIVE TECHNOLOGY LLC
NIH R41: I-Corps - Developing of a computer-based multimodal mind and body approach for mild cognitive decline
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PRAPELA, INC.
NIH U44: Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.
startup · ME · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SACYL PHARMACEUTICALS, INC.
NIH R43: Advancing a novel on-demand non-hormonal male contraceptive to IND enablement
startup · CT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BioMedInnovations LLC
Form D history: Biotechnology
startup · NC · amount not stated · 2024-04-10
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-04-10.
- VASCULAR VISION PHARMACEUTICALS COMPANY
NIH R44: Sulfated Non-Anticoagulant Heparin Nanoparticle (VVP728) for Sickle Cell Disease Management
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ANVIL DIAGNOSTICS INC.
NIH R43: Rapid and Highly Multiplexed Pathogen Detection for Sepsis Patients with Compressed Sensing and Digital PCR
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- INSPIRE RX LLC
NIH R44: Personal Respiratory Isolation System for Safe Transport and Treatment of Patients with Highly Transmissible Infectious Diseases
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- O2M TECHNOLOGIES, LLC
NIH R44: Advanced Imaging Methods in Pulse EPR
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HELICAL BIOSCIENCES LLC
NIH R41: Commercial production of alpha-synuclein fibrils amplified from human postmortem brain tissue to expand the availability of a critical research tool for Parkinson's disease
startup · MO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- REELIN THERAPEUTICS, INC.
NIH R41: Identification of next generation gamma-secretase modulators for Alzheimer's disease
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Lila Biologics
Lila Biologics is developing protein therapeutics to address high unmet medical needs, leveraging AI-powered protein design for therapeutic applications.
startup · WA · amount not stated · 2023-09-28
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-09-28.
- Outcome Referrals, Inc.
Form D history: Other Technology
startup · MA · amount not stated · 2025-08-20
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-08-20.
- REMEDI, INC.
NIH R43: Enhancing Oral Bioavailability of DMT with a Proprietary Reversible Monoamine Oxidase Inhibitor (RIMA) for Alcohol Use Disorder Therapy
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Oncternal Therapeutics, Inc.
Form D history: Biotechnology
startup · CA · amount not stated · 2020-12-22
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2020-12-22.
- ASKO THERAPEUTICS, INC.
NIH R43: Novel injectable implants for long-term local controlled release of therapeutic monoclonal antibodies
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HELIXOMER, INC.
NIH R44: Development of an RNA-based anticoagulant and antidote for precise on/off coagulation control during cardiovascular procedures
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SYNAPTIC HEALTH LLC
NIH R43: A novel closed-loop feedback neuromodulation system for improving slow wave sleep in Alzheimer's disease patients
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MEDICAL CYBERWORLDS, INC.
NIH R44: Modeling Professional Attitudes and Teaching Humanistic Communication to Remedy Implicit Bias and Promote Cultural Humility in Healthcare (MPathic-IBCH).
startup · WI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ARBOR MEDICAL INNOVATIONS, LLC
NIH U44: Actigraphy Enhanced Clinical Chronic Lower Back Pain Management: Sleep Algorithm Assessment
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AMLAL PHARMACEUTICALS INC
NIH R41: Development of a small molecule radiosensitizer for treatment of brain-metastatic non-small cell lung cancer
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HYDROGENE THERAPEUTICS INC
NIH R44: Developing Hydrodynamic Injection through Biliary System for the Treatment of Wilson's Disease
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Cytorum, Inc.
Form D history: Biotechnology
startup · CA · amount not stated · 2022-04-13
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2022-04-13.
- Exai Bio
Exai Bio’s next-generation RNA-based platform delivers actionable insight into cancer biology from a simple blood draw, revolutionizing how we diagnose, treat, and manage cancer.
startup · CA · amount not stated · 2022-10-11
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2022-10-11.
- OVARYIT, LLC
NIH R44: Development and commercialization of support tools to improve safety and efficiency of pharmacist-prescribed contraceptive services
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CONIFER POINT PHARMACEUTICALS, LLC
NIH R44: An Open Web Service For Fragment-based Design of Small Molecule Inhibitors
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VELUM, INC.
NIH R42: A Robust Platform for Design and Development of Therapeutic Peptides for Metabolic Syndrome
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HabitAware
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CASCADE METRIX, LLC
NIH R44: Automated Multiplex Analyzer for Sepsis and Beyond
startup · IN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GEEGAH LLC
NIH R43: Transforming C. Elegans Research Through Gigahertz Ultrasonic Imaging Microscopy
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EYSZ, INC.
NIH R43: A Mobile Health Application to Detect Absence Seizures using Hyperventilation and Eye-Movement Recordings
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PRECISIONBIO AI, LLC
NIH R43: Machine Learning-Driven Precision Dosing System for Improved Anticoagulation Therapy
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NP PHOTONICS, INC.
NIH R43: Low-cost robust compact 900 nm femtosecond laser source for two-photon microscopy
startup · AZ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LASE INNOVATION INC.
NIH R44: DNA-optical barcoding technology for spatiotemporal single-cell analysis
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Myogenica Inc.
Form D history: Biotechnology
startup · MN · amount not stated · 2022-03-28
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2022-03-28.
- CHROMOLOGIC, LLC
NIH R42: NGS based metagenomic screening of ocular infections
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Onconaut Therapeutics, Inc.
Form D history: Biotechnology
startup · CO · amount not stated · 2024-11-04
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-11-04.
- EVODENOVO, INC.
NIH R44: Development of small molecule therapeutics for mitigating opioid withdrawal syndrome
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NOVAFLUX, INC.
NIH R44: Novel hand hygiene product to remove Clostridioides difficile spores
startup · NJ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MAGNETIC TIDES, INC.
NIH R44: Exploring the Parameter Space of High Frequency Magnetic Perturbation in Manipulating Neural Excitability and Plasticity.
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ARIETIS
NIH R44: Development of a Dual-Targeting ClpP Activating Antibiotic
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.